FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2097643513> ?p ?o ?g. }

• W2097643513 abstract "A “substantial evidence” of effectiveness is required for new cancer treatment regimens to be approved. Objective tumor shrinkage/enlargement has been adopted as an indicator of drugs efficacy. The change of tumor size is assessed and quantified by various radiological techniques; most commonly computed tomography (CT). A high accuracy and reproducibility is, for obvious reasons, necessary in order to achieve a meaningful evaluation of such studies. For that purpose, the World Health Organization criteria (WHO-criteria) were launched in 1979 followed by the Response Evaluation Criteria In Solid Tumors (RECIST) in 2000 and the updated version RECIST 1.1 in 2009. There are, however, still several steps that may deteriorate consistencies. The purpose of this thesis was to investigate causes that may affect inconsistency in evaluation procedure according to RECIST (study I and II) and to explore the percentage of tumor size change at the first follow-up CT as the potential new surrogate indicators for OS in patient with metastatic colorectal cancer (mCRC) (study III) and in patient with metastatic breast cancer (MBC) (study IV). The number of discordant cases increased gradually when assessing fewer target lesions. Measuring fewer than four target lesions might cause discrepancies when more than five target lesions were present (study I). Interobserver variation using RECIST and WHOcriteria were moderate: 0.53 (95%CI 0.33 0.72) and 0.60 (0.39 – 0.80), respectively. Intraobserver variation using RECIST and WHO-criteria were substantial to perfect that ranged between 0.76 – 0.96 and 0.86 – 0.91, respectively (study II). The initial change in tumor size 8 weeks after initiation of chemotherapy was prognostic for PFS: Hazard Ratio (HR) 2.21, 95%CI 1.97 – 2.49, and OS: HR2.01, 95%CI 1.75 – 2.31, in mCRC (study III). The initial change in tumor size also correlated with OS in MBC (study IV). A marked difference in OS between patients with or without new lesion was demonstrated in mCRC: HR 3.77, 95%CI 2.08 – 6.83 (study III) and in MBC: HR 4.29, 95%CI 2.44 – 7.53 (study IV). In conclusion, the current tumor response evaluation criteria are associated with several subjective steps that may cause inconsistent results. The initial change in tumor size at the first follow-up CT may provide an alternative surrogate outcome. The findings obtained in this thesis may improve the development of future response evaluation criteria. ISBN 978-91-7457-812-6 LIST OF PUBLICATIONS I. DARKEH, M. H., SUZUKI, C. & TORKZAD, M. R. 2009. The minimum number of target lesions that need to be measured to be representative of the total number of target lesions (according to RECIST). Br J Radiol, 82, 681-6. II. SUZUKI, C., TORKZAD, M. R., JACOBSSON, H., ASTROM, G., SUNDIN, A., HATSCHEK, T., FUJII, H. & BLOMQVIST, L. 2010. Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria. Acta Oncol, 49, 509-14. III. SUZUKI, C., BLOMQVIST, L., SUNDIN, A., JACOBSSON, H., BYSTROM, P., BERGLUND, A., NYGREN, P. & GLIMELIUS, B. 2012. The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol, 23, 948-54. IV. SUZUKI, C., BLOMQVIST, L., HATSCHEK, T.,CARLSSON, L., EINBEIGI, Z., LINDERHOLM, B., LINDH, B., LOMAN, N., MALMBERG, M., ROTSTEIN, S., SODERBERG, M., SUNDQUIST, M., WALZ, T., ASTROM, G., FUJII, H., JACOBSSON, H., GLIMELIUS, B. Impact of early response on overall survival in metastatic breast cancer patients treated with combination chemotherapy within a randomized phase III trial (submitted manuscript) V. Appendix SUZUKI, C., JACOBSSON, H., HATSCHEK, T., TORKZAD, M. R., BODEN, K., ERIKSSON-ALM, Y., BERG, E., FUJII, H., KUBO, A. & BLOMQVIST, L. 2008. Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics, 28, 329-44. (Review Article)" @default.
• W2097643513 created "2016-06-24" @default.
• W2097643513 creator A5033625204 @default.
• W2097643513 date "2012-08-28" @default.
• W2097643513 modified "2023-09-26" @default.
• W2097643513 title "Computed tomography based assessment of treatment response in solid tumors" @default.
• W2097643513 cites W1437839308 @default.
• W2097643513 cites W1535149704 @default.
• W2097643513 cites W1812456385 @default.
• W2097643513 cites W1864670886 @default.
• W2097643513 cites W1913548007 @default.
• W2097643513 cites W1966648862 @default.
• W2097643513 cites W1966960520 @default.
• W2097643513 cites W1967849976 @default.
• W2097643513 cites W1969324628 @default.
• W2097643513 cites W1970351257 @default.
• W2097643513 cites W1979659182 @default.
• W2097643513 cites W1981989535 @default.
• W2097643513 cites W1985046983 @default.
• W2097643513 cites W2001797895 @default.
• W2097643513 cites W2019607817 @default.
• W2097643513 cites W2023890601 @default.
• W2097643513 cites W2024029636 @default.
• W2097643513 cites W2024167844 @default.
• W2097643513 cites W2025363005 @default.
• W2097643513 cites W2028269517 @default.
• W2097643513 cites W2031040180 @default.
• W2097643513 cites W2035395561 @default.
• W2097643513 cites W2038383343 @default.
• W2097643513 cites W2041179404 @default.
• W2097643513 cites W2045082601 @default.
• W2097643513 cites W2045800222 @default.
• W2097643513 cites W2052702202 @default.
• W2097643513 cites W2057705243 @default.
• W2097643513 cites W2057728542 @default.
• W2097643513 cites W2069703793 @default.
• W2097643513 cites W2075351817 @default.
• W2097643513 cites W2078646154 @default.
• W2097643513 cites W2082457815 @default.
• W2097643513 cites W2084243398 @default.
• W2097643513 cites W2084905853 @default.
• W2097643513 cites W2086260870 @default.
• W2097643513 cites W2093839744 @default.
• W2097643513 cites W2096340454 @default.
• W2097643513 cites W2096491867 @default.
• W2097643513 cites W2096900586 @default.
• W2097643513 cites W2098223440 @default.
• W2097643513 cites W2099146388 @default.
• W2097643513 cites W2101073067 @default.
• W2097643513 cites W2101272455 @default.
• W2097643513 cites W2101719282 @default.
• W2097643513 cites W2104389711 @default.
• W2097643513 cites W2104804192 @default.
• W2097643513 cites W2106789440 @default.
• W2097643513 cites W2107907914 @default.
• W2097643513 cites W2108549165 @default.
• W2097643513 cites W2108904969 @default.
• W2097643513 cites W2111109154 @default.
• W2097643513 cites W2111534292 @default.
• W2097643513 cites W2112561886 @default.
• W2097643513 cites W2114382024 @default.
• W2097643513 cites W2114447587 @default.
• W2097643513 cites W2115731038 @default.
• W2097643513 cites W2116290933 @default.
• W2097643513 cites W2116781863 @default.
• W2097643513 cites W2117858690 @default.
• W2097643513 cites W2117930351 @default.
• W2097643513 cites W2120079339 @default.
• W2097643513 cites W2121175754 @default.
• W2097643513 cites W2122334493 @default.
• W2097643513 cites W2122538591 @default.
• W2097643513 cites W2123534406 @default.
• W2097643513 cites W2124589535 @default.
• W2097643513 cites W2125415278 @default.
• W2097643513 cites W2128352793 @default.
• W2097643513 cites W2129689211 @default.
• W2097643513 cites W2130265908 @default.
• W2097643513 cites W2130457641 @default.
• W2097643513 cites W2132128432 @default.
• W2097643513 cites W2133892598 @default.
• W2097643513 cites W2135883845 @default.
• W2097643513 cites W2138297714 @default.
• W2097643513 cites W2139248078 @default.
• W2097643513 cites W2145262308 @default.
• W2097643513 cites W2150568050 @default.
• W2097643513 cites W2153477391 @default.
• W2097643513 cites W2153584585 @default.
• W2097643513 cites W2153982924 @default.
• W2097643513 cites W2154221980 @default.
• W2097643513 cites W2155263737 @default.
• W2097643513 cites W2157113469 @default.
• W2097643513 cites W2157118246 @default.
• W2097643513 cites W2158383057 @default.
• W2097643513 cites W2159339017 @default.
• W2097643513 cites W2160858189 @default.
• W2097643513 cites W2162439819 @default.
• W2097643513 cites W2164090407 @default.
• W2097643513 cites W2164310161 @default.
• W2097643513 cites W2164547129 @default.
• W2097643513 cites W2166602936 @default.

• next